Summary
Multiple hemostatic changes occur in sepsis and multiple organ failure (MOF). To evaluate the role of platelets in patients with sepsis and MOF, we examined changes in surface glycoproteins on circulating platelets of 14 patients with suspected sepsis and MOF. The severity of sepsis and MOF was assessed by the Elebute and APACHE II scoring systems, respectively. Using flow cytometric techniques and platelet specific monoclonal antibodies, platelet surface expression of fibrinogen receptor on GPIIb-IIIa, of von Willebrand Factor receptor GPIb, and of granule glycoproteins (thrombospondin (TSP), GMP-140, GP53) was measured. Plasma membrane expression of GPIIb-IIIa and GPIb on circulating platelets was not affected by sepsis or MOF. Septic patients, however, showed a significantly elevated fibrinogen receptor activity (LIBS1 expression) (p<0.05) that correlated with severity of disease (r=0.597, p=0.043). No significant change in surface expression of granule glycoproteins (TSP, GMP-140, GP53) was noted in septic patients. In contrast, degranulation of granule glycoproteins was significantly elevated in MOF (p<0.05) which correlated well with severity of MOF (GMP-140, r=0.611, p=0.013; TSP, r=0.643, p=0.026). We speculate that platelets in sepsis circulate in a hyperaggregable but still reversible state that results in increased risk of microthrombotic events. In the course of the disease, irreversible platelet degranulation of adhesion molecules occurs that may play an important role in the development of MOF.
Zusammenfassung
Ziel der vorliegenden Pilotstudie war es, die Thrombozytenfunktion von 14 Intensivpatienten mit unterschiedlicher Ausprägung von Sepsis und Multiorganversagen (MOV) zu untersuchen. Schweregrad der Sepsis und des MOV wurde anhand intensivmedizinischer Scoresysteme (APACHE II, Elebute) beurteilt. Die Thrombozytenfunktion wurde durch durchflußzytometrische Bestimmung von membranständigen Glykoproteinen (GPIIb-IIIa, GPIb, Thrombospondin (TSP), GMP-140, GP53) untersucht. Weder Sepsis noch MOV beeinflußten die Oberflächen-expression von GPIIb-IIIa oder GPIb. Die Aktivierung des Fibrinogenrezeptors war jedoch bei Sepsis deutlich erhöht (p<0.05) und korrelierte signifikant mit dem Schweregrad der Erkrankung (r=0,597, p=0,043). Eine signifikant gesteigerte Degranulation der Thrombozyten bei Sepsis konnte jedoch nicht beobachtet werden. Im Gegensatz dazu war die thrombozytäre Freisetzung von Granula-Glykoproteinen (TSP, GMP-140, GP53) bei MOV deutlich erhöht (p<0,05) und korrelierte mit dem Schweregrad der Erkrankung (GMP-140, r=0,611, p=0,013; TSP, r=0,643, p=0,026). Die Ergebnisse dieser Arbeit zeigen, daß Blutplättchen in Patienten mit Sepsis in einem aktivierten jedoch noch reversiblen Aggregationszustand zirkulieren (Aktivierung des Fibrinogenrezeptors), einhergehend mit einem erhöhten Risiko von Mikrothrombosen. Im Laufe der Erkrankung kann es zur gesteigerten Freisetzung und Oberflächenexpression von thrombozytären Glykoproteinen kommen, die eine entscheidende pathophysiologische Rolle in der Entwicklung von Mikrozirkulationsstörungen und MOV spielen könnten.
Similar content being viewed by others
References
Machiedo, G. W., Loverme, P. J., McGovern, P. J., Blackwood, J. M. Patterns of mortality in a surgical intensive care unit. Surg. Gyn. Obst. 152 (1981) 757–759.
Knaus, W. A., Draper, E. A., Wagner, D. P., Zimmermann, J. E. Prognosis in acute organ-system failure. Annals Surg. 202 (1985) 685–693.
Barton, R., Cerra, F. B. The hypermetabolism multiple organ failure syndrome. Chest 96 (1989) 1153–1159.
Saldeen, T. Clotting, microembolism, and inhibition of fibrinolysis in adult respiratory distress. Surg. Clin. North Am. 63 (1983) 285–304.
Parker, M. M., Parrillo, J. E. Septic shock: hemodynamics and pathogenesis. JAMA 250 (1983) 3324–3327.
Parrillo, J. E., Parker, M. M., Natanson, C., Suffredini, A. F., Danner, R. L., Connion, R. E., Ognigene, F. P. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann. Int. Med. 113 (1990) 227–242.
Vaage, J. Intravascular platelet aggregation and acute respiratory insufficiency. Circ. Shock. 122 (1977) 279–290.
Schneider, R. C., Zapol, W. M., Carvalho, A. C. Platelet consumption and sequestration in severe acute respiratory distress syndrome. Am. Rev. Respir. Dis. 122 (1980) 445–451.
George, J. N., Pickett, E. B., Saucerman, S., McEver, R. P., Kunicki, T. J., Kieffer, N., Newman, P. J. Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane micro-particles in normal subjects, and observation in patients during adult respiratory distress syndrome and cardiac surgery. J. Clin. Invest. 78 (1986) 340–348.
Schirmer, W. J., Fry, D. E.: Microcirculatory arrest. In:Frey, D. E.: (ed.): Multiple system organ failure — pathogenesis and management. Mosby-Yearbook, Inc. 1992, pp. 73–85.
George, J. N., Nurden, A. T., Phillips, D. R. Molecular defects in interactions of platelets with the vessel wall. N. Engl. J. Med. 311 (1984) 1084–1098.
Ginsberg, M. H., Loftus, J. C., Plow, E. F. Cytoadhesins, integrins, and platelets. Thromb. Haemostasis 59 (1988) 1–6.
Ginsberg, M. H., Frelinger, A. L., Lam, S. C. T., Forsyth, J., McMillan, R., Plow, E. F., Shattil, S. J. Analysis of platelet aggregation disorders based on flow cytometric analysis of platelet membrane glycoprotein IIb-IIIa with conformation specific monoclonal antibodies. Blood 76 (1990) 2017–2023.
Gawaz, M. P., Loftus, J. C., Bajt, M. L., Frojmovic, M. M., Plow, E. F., Ginsberg, M. H. Ligand binding mediates integrin αIIbβ3 (platelet GPIIb-IIIa) dependent homotypic and heterotypic cell-cell interaction. J. Clin. Invest. 88 (1991) 1128–1134.
Asch, A. S., Nachman, R. L.: Thrombospondin: phenomenology to function. In:Coller, B. S.: (ed.): Progress in hemostasis and thrombosis. W. B. Saunders Company 1989, Vol. 9, pp. 157–176.
Stenberg, D. E., McEver, R. P., Shuman, M. A., Jacques, Z. V., Bainton, D. F. A platelet membrane glycoprotein (GMP-140) is expressed on the plasma membrane after activation. J. Cell. Biol. 101 (1985) 880–886.
Nieuwenhuis, H. K., Oosterhoutvon, J. J. G., Rosemuller, E., Iwaarden van, F., Sixma, J. J. Studies with a monoclonal antibody against activated platelets. Evidence that a secreted Mw 53,000 lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood 70 (1987) 838–845.
Leung, L., Nachman, R. Molecular mechanisms of platelet aggregation. Ann. Rev. Med. 37 (1986) 179–186.
Hamburger, S. A., McEver, R. P. GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood 75 (1990) 550–555.
Rinder, H. M., Bonan, J. L., Rinder, C. S., Ault, K. A., Smith, B. R. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood 78 (1991) 1760–1769.
Pilz, G., Gurniak, T., Bujdoso, O., Werdan, K. A BASIC program for calculation of APACHE II and Elebute scores and sepsis evaluation in intensive care medicine. Comput. Biol. Med. 21 (1991) 143–159.
Knaus, W. A., Draper, E. A., Wagner, D. P., Zimmerman, J. E. APACHE II: a severity of disease classification system. Crit. Care Med. 13 (1985) 818–829.
Elebute, E. A., Stoner, H. B. The grading of sepsis. Br. J. Surg. 70 (1983) 29–31.
Grundmann, R., Kipping, N., Wesoly, C. Der Sepsisscore von Elebute und Stoner zur Definition der postoperativen Sepsis auf der Intensivstation. Intensivmedizin 25 (1988) 268–273.
Gawaz, M. P., Ward, R. A. Effects of hemodialysis on platelet-derived thrombospondin. Kidney Int. 40 (1991) 257–265.
Tschöpe, D., Schwippert, B. DIII-Assay/Bestimmung von Aktivierungsmarkern auf Thrombozyten im Durchflußzytometer. In:Schmitz, G., Rothe, G. (eds.): Durchflußzytometrie in der klinischen Zelldiagnostik. Schattauer Verlag Stuttgart, New York 1994, pp. 433–442.
Gawaz, M. P., Bogner, C., Gurland, H. J. Flow cytometric analysis of mepacrine labelled platelets in patients with end-stage renal failure. Hacmostasis 23 (1993) 284–292.
Gawaz, M. P., Bogner, C. Changes in platelet membrane glycoproteins and platelet-leukocyte interaction during hemodialysis. Clin. Invest. 72 (1994) 424–429.
Gawaz, M. P., Dobos, G., Späth, M., Schollmeyer, P., Gurland, H. J., Mujais, S. J. Impaired function of platelet membrane glycoprotein IIb-IIIa in end-stage renal disease. J. Am. Soc. Nephrol. 5 (1994) 36–46.
Gawaz, M. P., Mujais, S., Schmidt, B., Gurland, H. J. Platelet-leukocyte aggregation during hemodialysis. Kidney Int. 46 (1994) 489–495.
Böck, M., Gawaz, M. P., Dietzler, A., Heim, M. U., Mempel, W. Single-donor platelet concentrates: changes of surface glycoproteins during storage. Haemostasis 24 (1994) 230–235.
Gawaz, M. P., Mayinger, P., Neumann, F. J. Effect of ATP on ligand recognition of platelet fibrinogen receptor on GPIIb-IIIa. Am. J. Physiol. 267 (1994) H1098-H1106.
Gawaz, M., Ott, I., Reininger, A. J., Neumann, F. J.: Effects of magnesium on platelet aggregation and adhesion. Magnesium modulates surface expression of glycoproteins on plateletsin vitro andex vivo. Thromb. Haemost. 72 (1994) (in press).
Saba, T. M., Fortune, J. B., Wallace, J. R.: Microaggregation hypothesis of multiple system organ failure. In:Frey, D. E.: (ed.): Multiple system organ failure — pathogenesis and management. Mosby-Yearbook, Inc. 1992, pp. 25–41.
Heffner, J. E., Sahn, S. A., Repine, J. E. The role of platelets in adult respiratory distress syndrome. Am. Rev. Respir. Dis. 135 (1987) 482–492.
Neame, P. B., Kelton, J. G., Walker, I. R., Stewart, I. O., Nossel, H. L., Hirsh, J. Thrombocytopenia in septicemia: the role of disseminated intravascular coagulation. Blood 56 (1980) 88–92.
Kelton, J. G., Neame, P. B., Gauldie, J., Hirsh, J. Elevated platelet-associated IgG in the thrombocytopenia of septicemia. N. Engl. J. Med. 300 (1979) 760–764.
Siess, W. Molecular mechanisms of platelet activation. Physiol. Rev. 69 (1989) 50–178.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gawaz, M., Fateh-Moghadam, S., Pilz, G. et al. Severity of multiple organ failure (MOF) but not of sepsis correlates with irreversible platelet degranulation. Infection 23, 16–23 (1995). https://doi.org/10.1007/BF01710051
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01710051